Consumer staples oversold on GLP-1 fears — buy the overreaction, collect dividends
Beaten Down Staples (GLP-1 Fear) 3Y
| Symbol | Action | Vol | Stop Loss | Take Profit | Size | Links |
|---|---|---|---|---|---|---|
| MDLZ | BUY | 22% | 12.6% below entry | 4.5% above entry | 6.0% | TVYH |
This strategy is suitable for passive investing. It has shown consistent returns across multiple time horizons. Entry: Buy the recommended positions at any time. Use the position sizes above as your target allocation. Rebalance: Check quarterly. If any position has drifted more than 5% from target, rebalance back. Exit rules: - Take profit: Rebalance when any position exceeds 2x its target weight. Trim back to target, redeploy to underweight positions. - Stop loss: NO price-based stop loss. This strategy recovered from -24% drawdown to return 116% over the long term. Stopping out would have locked in losses. - Exit rule: Exit if GLP-1 drug adoption exceeds 15% of US adult population — at that point the selloff is justified, not overreaction.